• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. DIMENSION®; DIMENSION® HB1C HEMOGLOBIN A1C KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. DIMENSION®; DIMENSION® HB1C HEMOGLOBIN A1C KIT Back to Search Results
Catalog Number DF105A SMN 10483822
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/08/2019
Event Type  malfunction  
Manufacturer Narrative
Siemens healthcare diagnostics headquarters support center (hsc) concluded their investigation of the discordant, falsely elevated hemoglobin a1c (hb1c) results.The siemens hb1c assay is cleared for monitoring diabetic therapy and not for use in the diagnosis of diabetes.All hb1c assay results processed by the dimension exl 200 instrument were within the instructions for use reference range for adults without suspected diabetes.The customer using the hb1c assay beyond what it is cleared for or beyond the hb1c assay intended use is not supported by siemens.The issue was caused by customer user error.No product non-conformance was identified.The device is performing within specifications.No further evaluation is required.
 
Event Description
Discordant, falsely elevated hemoglobin a1c (hb1c) results were obtained on patient samples on the dimension exl 200 instrument on (b)(6) 2019.The results were reported to the physician (s) and were questioned.The same samples were reprocessed using an alternate methodology on a non-siemens instrument on the same date and lower hemoglobin a1c results were obtained.On (b)(6) 2019, siemens was informed that the physicians (s) regarded the dimension hb1c results as high and started treatment for pre-diabetes.The type of treatment was not specified.There was no alleged patient harm due to the discordant elevated hb1c results or due to the treatment.
 
Manufacturer Narrative
Original mdr 2517506-2019-00174 was filed 29-apr-2019.Corrected information (06-may-2019): siemens was informed that the correct date of testing for sample id 1017275409 for hb1c is 18-mar-2019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIMENSION®
Type of Device
DIMENSION® HB1C HEMOGLOBIN A1C KIT
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
500 gbc drive
po box 6101
newark DE 19714 6101
MDR Report Key8561220
MDR Text Key151134237
Report Number2517506-2019-00174
Device Sequence Number1
Product Code LCP
UDI-Device Identifier00842768032615
UDI-Public00842768032615
Combination Product (y/n)N
PMA/PMN Number
K102510
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 05/31/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/29/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/09/2019
Device Catalogue NumberDF105A SMN 10483822
Device Lot NumberGC9190
Was Device Available for Evaluation? No
Date Manufacturer Received05/06/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-